Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998

International Journal of Antimicrobial Agents

Volumn 16, Issue 4, 2000, Pages 401-405

  Huczko, E ^a   Conetta, B ^a   Bonner, D ^a   Valera, L ^a   Stickle, T ^a   Macko, A ^a   Fung Tomc, J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Ciprofloxacin; Gatifloxacin; Quinolones

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONADACEAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CLINICAL TRIALS; ENTEROBACTERIACEAE; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033675676     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00223-5     Document Type: Article

References (24)

1. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone
2. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone
3. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp
4. The activity of the methylpiperazinyl fluoroquinolone CG 5501: A comparison with other fluoroquinolones
5. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
6. Antibacterial properties of AM-1155, a new 8-methoxy quinolone
7. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC
8. Comparative in vitro and in vivo activity of AM-1155 against anaerobic bacteria
9. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin
10. In vitro and in vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae
11. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae
12. In-vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone gatifloxacin
13. Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: Contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)
14. Gatifloxacin activity against quinolone-resistant gyrase: Allele-specific enhancement of bacteriostatic and bactericidal activity by the C-8-methoxy group
15. DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
16. Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus
17. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital
18. Antibacterial activity of gatifloxacin (AM-1155, CG 5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus